Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria
Clinical trial NCT05170724 · AVAILABLE
Trial details
- NCT number
- NCT05170724
- Sponsor
- Novartis Pharmaceuticals
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.